info@mail.ucallm.com
From Cellular Aging to Fibrotic Progression — Empowering Mechanistic Investigation of Senescence, SASP Signaling, and Tissue Remodeling with Validated Antibody Solutions
Cellular senescence is a complex stress-adaptive state driven by persistent cell-cycle arrest, metabolic reprogramming, altered chromatin architecture, and secretion of pro-inflammatory factors collectively known as the senescence-associated secretory phenotype (SASP). While senescence serves as an essential mechanism for preventing uncontrolled cell proliferation, the persistent accumulation of senescent cells during aging and chronic injury promotes inflammatory amplification, extracellular matrix (ECM) remodeling, tissue dysfunction, and irreversible fibrotic progression.
Across organs including the lung, kidney, liver, cardiovascular system, and aging-associated tissues, senescent cells act as key regulators of the fibrotic microenvironment by reshaping cellular communication, activating fibroblast responses, and driving excessive matrix deposition. Understanding the molecular links between senescence and fibrosis is critical for identifying biomarkers, therapeutic targets, and intervention strategies for age-related and chronic fibrotic diseases.Senescence-driven fibrosis is regulated through coordinated molecular networks involving:
- Cell-cycle arrest and senescence establishment
- DNA damage response and genomic instability
- SASP-mediated inflammatory amplification
- TGF-β/SMAD-dependent fibrotic signaling
- Fibroblast activation and ECM deposition
- Metabolic and stress-response pathways
Our validated antibody portfolio enables comprehensive characterization of:
- Senescent cell identification and molecular profiling
- SASP-associated inflammatory signaling
- Fibroblast activation and myofibroblast transition
- ECM remodeling and collagen deposition
- Senescence–fibrosis signaling mechanisms
- Therapeutic target discovery for aging-associated diseases
Senescence-Associated Fibrosis Biomarker Antibody Portfolio
—Comprehensive Solutions for Cellular Senescence Detection, SASP Profiling, and Fibrotic Remodeling Analysis
Cellular senescence and fibrosis are interconnected biological processes driven by persistent stress signals, inflammatory activation, and extracellular matrix remodeling.
Our antibody portfolio provides validated research tools targeting key molecular events involved in:
Research Focus | Key Targets | Research Applications |
Cellular Senescence Identification | p16/CDKN2A, p21/CDKN1A, p53, Lamin B1, γ-H2AX, Ki-67 | Detection of senescence induction, cell-cycle arrest, DNA damage accumulation, and proliferative decline |
Senescence-Associated Secretory Phenotype (SASP) | IL-6, IL-1β, IL-8/CXCL8, TNF-α, TGF-β1, MMP3, HMGB1, PAI-1/SERPINE1 | Profiling inflammatory cytokine secretion and SASP-driven tissue remodeling |
Fibroblast Activation & Myofibroblast Transition | ACTA2 (α-SMA), VIM, FAP, CTGF (CCN2) | Characterization of fibroblast activation and acquisition of fibrotic phenotypes |
Extracellular Matrix Remodeling | COL1A1, COL3A1, Fibronectin/FN1 | Analysis of collagen deposition, ECM accumulation, and fibrosis progression |
Senescence–Fibrosis Signaling Networks | TGFBR1, TGFBR2, SMAD2, SMAD3, p-SMAD2 (Ser465/467), p-SMAD3 (Ser423/425), MAPK3 (ERK1), MAPK1 (ERK2), Phospho-p44/42 MAPK (Thr202/Tyr204) | Investigation of canonical and noncanonical pathways regulating fibrosis |
Inflammatory & Metabolic Regulation | CGAS, STING1, RELA (p65), MTOR, PANX1 | Study of DNA sensing, inflammatory amplification, metabolic adaptation, and senescence maintenance |
Key Targets in Senescence Establishment & Fibrotic Progression
—Molecular Regulators Driving Cellular Aging, Inflammation, and Tissue Remodeling
Persistent cellular stress activates senescence programs characterized by cell-cycle arrest, DNA damage accumulation, and inflammatory signaling. Senescent cells release SASP factors that stimulate fibroblast activation and promote pathological ECM deposition.
Key Target | Biological Role | Antibody Research Application |
p16/CDKN2A | Canonical senescence marker inducing RB-dependent cell-cycle arrest | Identification and quantification of senescent cell populations |
p21/CDKN1A | p53-responsive regulator controlling stress-induced growth arrest | Monitoring early senescence activation |
p53/TP53 | Master regulator of DNA damage response and senescence initiation | Analysis of stress-induced senescence pathways |
Lamin B1 | Nuclear structural protein frequently reduced during senescence | Detection of senescence-associated nuclear remodeling |
γ-H2AX | Marker of persistent DNA damage signaling | Evaluation of senescence-associated DNA damage foci |
Ki-67 | Proliferation marker reduced during senescence | Assessment of proliferative capacity loss |
SASP Signaling Network
—Key Inflammatory Mediators Linking Cellular Senescence to Fibrotic Remodeling
The SASP program converts senescent cells into active signaling hubs that release cytokines, chemokines, growth factors, and matrix-remodeling enzymes, driving chronic inflammation and fibrosis.
Key Target | Biological Role | Antibody Research Application |
IL-6 | Major inflammatory SASP cytokine promoting chronic inflammation | SASP profiling and inflammatory pathway analysis |
IL-1β | Activates inflammatory cascades and cytokine amplification | Characterization of senescence-associated inflammation |
IL-8/CXCL8 | Chemokine involved in immune recruitment and tissue remodeling | Analysis of inflammatory microenvironment changes |
TGF-β1 | Central pro-fibrotic SASP factor | Investigation of fibrosis initiation mechanisms |
MMP3 | Matrix metalloproteinase regulating ECM remodeling | Evaluation of extracellular matrix turnover |
PAI-1/SERPINE1 | Senescence-associated regulator of fibrosis and extracellular matrix stability | Senescence-associated fibrosis biomarker analysis |
HMGB1 | Damage-associated molecular pattern protein | Study of inflammatory signaling activation |
Fibrotic Remodeling & ECM Deposition Panel
—Characterizing Fibroblast Activation, Myofibroblast Differentiation, and Matrix Accumulation
Fibrosis progression involves activation of fibroblasts, acquisition of myofibroblast characteristics, and excessive deposition of extracellular matrix proteins.
Key Target | Biological Role | Research Application |
α-SMA/ACTA2 | Hallmark marker of activated myofibroblasts | Detection of fibroblast-to-myofibroblast transition |
COL1A1 | Major collagen component of fibrotic ECM | Quantification of collagen accumulation |
COL3A1 | ECM structural component elevated during fibrosis | Evaluation of matrix remodeling |
Fibronectin/FN1 | ECM adhesion protein involved in fibrosis progression | Analysis of ECM organization |
FAP | Activated fibroblast marker | Identification of fibrosis-associated fibroblast populations |
Vimentin/VIM | Mesenchymal marker associated with fibroblast activation | Monitoring mesenchymal phenotype acquisition |
CTGF/CCN2 | Profibrotic growth factor downstream of TGF-β signaling | Investigation of fibrotic pathway activation |
Senescence–Fibrosis Signaling Pathway Panel
—Decoding Molecular Networks Connecting Aging, Inflammation, and Fibrotic Disease
Senescence-associated fibrosis is controlled by interconnected signaling pathways including TGF-β/SMAD, MAPK, cGAS–STING, NF-κB, and mTOR pathways.
Key Targets | Biological Function | Research Applications |
TGFBR1 / TGFBR2 | Mediate TGF-β receptor activation | Analysis of fibrosis initiation signals |
SMAD2/3 & p-SMAD2/3 | Canonical downstream mediators of TGF-β signaling | Monitoring pathway activation |
ERK1/2 & p-ERK1/2 | MAPK signaling regulators involved in fibrotic responses | Investigation of noncanonical fibrosis pathways |
cGAS/STING | Cytosolic DNA sensing pathway activating inflammation | Study of senescence-associated inflammatory responses |
NF-κB | Master transcriptional regulator of SASP production | Analysis of inflammatory gene regulation |
mTOR | Regulator of cellular metabolism and senescence maintenance | Investigation of aging-associated metabolic changes |
PANX1 | Regulates ATP release and inflammatory signaling | Study of senescence-associated extracellular communication |
Featured Senescence & Fibrosis Research Panels
—Integrated Antibody Solutions for Profiling Cellular Aging, SASP Activation, Fibrotic Remodeling, and Disease Progression
Cellular senescence and fibrosis are interconnected pathological processes driven by persistent cellular stress, inflammatory signaling, metabolic dysregulation, and extracellular matrix remodeling.
Our curated antibody panels enable comprehensive characterization of the senescence–inflammation–fibrosis axis, supporting mechanistic studies from early senescence induction to advanced tissue remodeling and therapeutic intervention.
Cellular Senescence Identification Panel—Defining Senescent Cell States and Stress-Induced Aging Phenotypes
Key Markers
p16/CDKN2A | p21/CDKN1A | p53 | Lamin B1 | γ-H2AX | Ki-67 |
SASP & Inflammatory Remodeling Panel—Characterizing Senescence-Associated Secretory Phenotype and Chronic Inflammation
Key Markers
IL-6 | IL-1β | IL-8/CXCL8 | TNF-α | TGF-β1 | MMP3 | PAI-1 | HMGB1 |
Fibroblast Activation & ECM Remodeling Panel—Monitoring Myofibroblast Transition and Fibrotic Matrix Deposition
Key Markers
α-SMA | COL1A1 | COL3A1 | Fibronectin | FAP | CTGF | Vimentin |
Multiplex Senescence & Fibrosis Spatial Profiling Panel—Visualizing Cellular Interactions Within the Fibrotic Microenvironment
Senescent Cells | p16 | p21 | Lamin B1 |
Fibroblast/Myofibroblast | α-SMA | FAP | Vimentin |
ECM Remodeling | COL1A1 | Fibronectin |
|
Inflammatory Signaling | IL-6 | NF-κB |
|
Why Researchers Choose Our Senescence & Fibrosis Antibody Solutions
Validated Senescence Biomarkers. Comprehensive Fibrosis Pathway Panels. Mechanistic Insights into Aging-Associated Disease Progression
Cellular senescence and fibrosis are interconnected biological processes involving cell-cycle arrest, SASP-mediated inflammation, fibroblast activation, extracellular matrix remodeling, and tissue dysfunction. Our validated antibody solutions support comprehensive investigation of senescence-driven fibrotic mechanisms—from molecular pathway activation to spatial characterization of diseased tissues.
Key Research Question | Validated Antibody Solutions |
How can I identify and validate senescent cell populations? | p16/CDKN2A, p21/CDKN1A, p53, Lamin B1, γ-H2AX, Ki-67 |
How can I characterize SASP activation and inflammatory remodeling? | IL-6, IL-1β, IL-8/CXCL8, TNF-α, TGF-β1, NF-κB, PAI-1/SERPINE1 |
How can I evaluate fibroblast activation and extracellular matrix deposition? | α-SMA/ACTA2, COL1A1, COL3A1, Fibronectin/FN1, FAP, CTGF/CCN2 |
How can I investigate TGF-β-driven fibrotic signaling? | TGFBR1, TGFBR2, SMAD2/3, p-SMAD2/3, ERK1/2, p-ERK1/2 |
How can I study aging-associated inflammation and stress responses? | cGAS-STING, NF-κB, mTOR, PANX1, ROS-related markers, NRF2 |
How can I visualize senescence and fibrosis within tissue microenvironments? | Multiplex IF/IHC-compatible senescence, inflammatory, and fibrosis biomarker panels |
Key reference
Chen H, Chen H, Liang J, Gu X, Zhou J, Xie C, Lv X, Wang R, Li Q, Mao Z, Sun H, Zuo G, Miao D, Jin J. Author Correction: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency. Exp Mol Med. 2024 Jun;56(6):1475-1477.
Yoo YJ, Zhang M, Jin SH, Lee YR, Jin H, Doan TP, Kim S, Choi S, Park EJ, Na S, Lee Y, Sun J, Cho J, Cho NC, Park SY, Oh WK, Lee YS. Targeting the senescence‒autophagy axis via p16INK4a inhibition alleviates pulmonary fibrosis. Signal Transduct Target Ther. 2026 Jun 15;11(1):234.
Lucas V, Cavadas C, Aveleira CA. Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies. Pharmacol Rev. 2023 Jul;75(4):675-713.
Huang L, Shen Y, Pan X, Li J, Li C, Ruan L, He S, Huang L, Liu K, Zhao X, Geng J, Guo J, Hou FF, Wang J. Noncanonical function of Pannexin1 promotes cellular senescence and renal fibrosis post-acute kidney injury. Nat Commun. 2025 Aug 19;16(1):7699.
Maus M, López-Polo V, Mateo L, Lafarga M, Aguilera M, De Lama E, Meyer K, Sola A, Lopez-Martinez C, López-Alonso I, Guasch-Piqueras M, Hernandez-Gonzalez F, Chaib S, Rovira M, Sanchez M, Faner R, Agusti A, Diéguez-Hurtado R, Ortega S, Manonelles A, Engelhardt S, Monteiro F, Stephan-Otto Attolini C, Prats N, Albaiceta G, Cruzado JM, Serrano M. Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. Nat Metab. 2023 Dec;5(12):2111-2130.
Bhardwaj S, Gautam RK, Kushwaha S. From senescence to scarring: Exploring TGF-β signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis. Cytokine Growth Factor Rev. 2025 Dec;86:29-39.
Su W, Guo Y, Wang Q, Ma L, Zhang Q, Zhang Y, Geng Y, Jin T, Guo J, Yang R, Niu Z, Ren L, Wang Y, Ning Z, Li W, He W, Sun J, Li T, Li Z, Shan H, Liang H. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. Exp Mol Med. 2024 Jul;56(7):1643-1654.
Parimon T, Hohmann MS, Yao C. Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis. Int J Mol Sci. 2021 Jun 9;22(12):6214.